首页> 美国卫生研究院文献>Thorax >Comparison of the acute effects on gas exchange of nasal ventilation and doxapram in exacerbations of chronic obstructive pulmonary disease.
【2h】

Comparison of the acute effects on gas exchange of nasal ventilation and doxapram in exacerbations of chronic obstructive pulmonary disease.

机译:比较慢性阻塞性肺疾病加重鼻通气和多沙普兰对气体交换的急性作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BACKGROUND: Nasal intermittent positive pressure ventilation (NIPPV) is useful in exacerbations of chronic obstructive pulmonary disease (COPD) complicated by ventilatory failure. The effects of NIPPV were compared with those of the respiratory stimulant doxapram on gas exchange in patients with COPD and acute ventilatory failure. METHODS: Patients admitted with acute exacerbations of COPD and type 2 respiratory failure (Pao2 < 8 kPa and PaCO2 > 6.7 kPa) who did not improve with conventional treatment were randomised to receive either NIPPV or intravenous doxapram. Blood gas tensions were monitored for four hours. RESULTS: In nine patients who received NIPPV the arterial PaO2 improved from a mean (SE) of 5.9 (0.4) kPa to a maximum of 8.1 (0.6) kPa which was maintained at four hours. Eight patients who received doxapram had a similar baseline Pao2 of 5.6 (0.4) kPa which rose to a maximum of 7.3 (0.5) kPa but this was not maintained at four hours. The improvement in Pao2 in patients on NIPPV was accompanied by a fall in Paco2 but, in contrast, in those who received doxapram there was no improvement in Paco2. CONCLUSIONS: NIPPV may be more effective than doxapram in the management of acute ventilatory failure complicating COPD.
机译:背景:鼻间歇性正压通气(NIPPV)在慢性阻塞性肺疾病(COPD)并发通气衰竭加重时非常有用。将NIPPV与呼吸刺激剂多沙普仑对COPD和急性通气衰竭的患者气体交换的影响进行了比较。方法:入院的COPD急性加重和2型呼吸衰竭(Pao2 <8 kPa和PaCO2> 6.7 kPa)未通过常规治疗改善的患者被随机分配接受NIPPV或静脉注射多沙普仑。监测血气张力四个小时。结果:在接受NIPPV的9例患者中,动脉PaO2从5.9(0.4)kPa的平均(SE)改善到维持4小时的最大8.1(0.6)kPa。接受多沙普仑的八名患者的基线Pao2相似,为5.6(0.4)kPa,最高上升至7.3(0.5)kPa,但四小时后并未维持。 NIPPV患者Pao2的改善伴有Paco2的下降,但是相比之下,接受多沙普仑的患者Paco2却没有改善。结论:NIPPV在多发性COPD急性通气衰竭的治疗中可能比多沙普仑更有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号